Strategic Analysis of World Psychiatric Therapeutics Markets

Strategic Analysis of World Psychiatric Therapeutics Markets

 

RELEASE DATE
28-Sep-2004
REGION
Global
Research Code: A847-01-00-00-00
SKU: HC00981-GL-MR_04857
AvailableYesPDF Download

$3,950.00

Special Price $2,962.50 save 25 %

In stock
SKU
HC00981-GL-MR_04857

$3,950.00

$2,962.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service evaluates the emerging psychiatric therapeutics markets, specifically anticonvulsants, antidepressants, and antipsychotics. Factors affecting market growth, existing market trends, pipeline trends, challenges, strategic product profiles, revenue analysis, and awards are presented for each therapeutic area.

Table of Contents

Overview

  • Introduction
  • Disclaimer
  • Certification
  • Research Scope and Methodology
  • Study Objectives
  • Market Segmentation by Geographical Region
  • Market Segmentation by Indications

Total Market Overview

  • Market Dynamics Overview
  • Research and Development Overview
  • Executive Quote

Anticonvulsant Markets

  • Introduction
  • Revenues by Geographical Regions
  • Revenue Forecast by Geographical Regions
  • Revenue Split by Product
  • Demand Analysis
  • Industry Challenges
  • Market Drivers
  • Market Restraints
  • Revenue Potential
  • Product Pipeline Analysis
  • Product Analysis: Pregabalin
  • Product Analysis: Rufinamide

Antidepressants Markets

  • Introduction
  • Revenues by Geographical Regions
  • Revenue Forecast by Geographical Regions
  • Revenue Split by Product
  • Demand Analysis
  • Percent of Treated vs. Untreated Patients
  • Industry Challenges
  • Market Drivers
  • Market Restraints
  • Product Pipeline Analysis
  • Product Analysis: Cymbalta
  • Product Analysis: DVS-233 SR
  • Product Analysis: Gepirone ER
  • Product Analysis: SR 58611

Antipsychotic Markets

  • Introduction
  • Revenues by Geographical Regions
  • Revenue Forecast by Geographical Regions
  • Revenue Split by Product
  • Industry Challenges
  • Market Drivers
  • Market Restraints
  • Product Pipeline Analysis
  • CEO Quote
  • Product Analysis: Bifeprunox

Competitive Landscape

  • Company Analysis
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Eli Lilly
  • Johnson and Johnson
  • Wyeth
  • Novartis
  • Forest Laboratories
  • Organon
  • Anticipating the Future

Frost & Sullivan Awards

  • Introduction
  • Competitive Strategy Leadership Award
  • Product Innovation Award - Antipsychotic Markets
  • Product Innovation Award - Antidepressant Markets
  • Growth Strategy Leadership Award

Decision Support Databases

  • Psychiatrics
  • Neurologists
  • Alzheimer's Patients
  • Population 65 and Above
  • Physicians

Frost & Sullivan

  • Healthcare Team
  • Our Capabilities
  • Key Advantages
  • Our Consulting Clients
  • Growth Consulting
  • Growth Consulting Process
  • Growth Consulting Deliverables
  • Growth Partnership Service
  • Growth Partnership Service Platform
This research service evaluates the emerging psychiatric therapeutics markets, specifically anticonvulsants, antidepressants, and antipsychotics. Factors affecting market growth, existing market trends, pipeline trends, challenges, strategic product profiles, revenue analysis, and awards are presented for each therapeutic area.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A847-01-00-00-00
Is Prebook No